Theradiag SA Cash Flow-to-Debt Ratio
Theradiag SA cash flow-to-debt ratio. Theradiag SA (ALTHE) has a Cash Flow-to-Debt Ratio of -0.25x as of June 2025, meaning its operating cash flow of €-3.56 Million could theoretically repay 0% of its total liabilities (€14.09 Million) in one year. See how financially flexible is Theradiag SA to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Theradiag SA (2011–2024)
Cash flow-to-debt ratio of Theradiag SA from 2011 to 2024. Historical debt coverage capacity for Theradiag SA across 14 annual periods. Also explore how fast is Theradiag SA growing its equity to track the company's year-over-year net asset growth rate.
Theradiag SA Cash Flow-to-Debt Ratio by Year (2011–2024)
Theradiag SA cash flow-to-debt ratio by year from 2011 to 2024. Year-by-year debt coverage analysis for Theradiag SA. For the full cash flow conversion analysis, see ALTHE cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.25x | €-2.91 Million | €11.47 Million | ▼ -32.9% |
| 2023 | -0.19x | €-2.48 Million | €13.01 Million | ▲ +51.4% |
| 2022 | -0.39x | €-5.27 Million | €13.40 Million | ▼ -32.6% |
| 2021 | -0.30x | €-3.88 Million | €13.10 Million | ▼ -23.0% |
| 2020 | -0.24x | €-3.32 Million | €13.78 Million | ▲ +30.9% |
| 2019 | -0.35x | €-3.69 Million | €10.59 Million | ▲ +25.6% |
| 2018 | -0.47x | €-4.73 Million | €10.10 Million | ▲ +28.9% |
| 2017 | -0.66x | €-6.79 Million | €10.30 Million | ▲ +24.5% |
| 2016 | -0.87x | €-7.97 Million | €9.13 Million | ▼ -48.9% |
| 2015 | -0.59x | €-4.98 Million | €8.50 Million | ▲ +37.7% |
| 2014 | -0.94x | €-5.18 Million | €5.51 Million | ▼ -57.0% |
| 2013 | -0.60x | €-4.04 Million | €6.75 Million | ▲ +34.8% |
| 2012 | -0.92x | €-2.66 Million | €2.90 Million | ▼ -110.8% |
| 2011 | -0.44x | €-952.02K | €2.19 Million | — |